Addition of metformin for non-small cell lung cancer patients receiving antineoplastic agents
Background and purpose: Previous studies have found that metformin can inhibit tumor growth and improve outcomes for cancer patients. However, the association between the addition of metformin to the treatment regimen and survival in non-small cell lung cancer (NSCLC) patients receiving antineoplast...
Kaydedildi:
Asıl Yazarlar: | , , , , |
---|---|
Materyal Türü: | Kitap |
Baskı/Yayın Bilgisi: |
Frontiers Media S.A.,
2023-03-01T00:00:00Z.
|
Konular: | |
Online Erişim: | Connect to this object online. |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|
Internet
Connect to this object online.3rd Floor Main Library
Yer Numarası: |
A1234.567 |
---|---|
Kopya Bilgisi 1 | Kütüphanede |